Version 5.4
Bos taurus Protein: BT.106212
Summary
InnateDB Protein IDBP-688880.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.106212
Protein Name sulfhydryl oxidase 1
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000018869
InnateDB Gene IDBG-636899 (BT.106212)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003756 protein disulfide isomerase activity
GO:0016491 oxidoreductase activity
GO:0016971 flavin-linked sulfhydryl oxidase activity
GO:0016972 thiol oxidase activity
Biological Process
GO:0006457 protein folding
GO:0045454 cell redox homeostasis
GO:0055114 oxidation-reduction process
Cellular Component
GO:0005615 extracellular space
GO:0030173 integral component of Golgi membrane
GO:0070062 extracellular vesicular exosome
Protein Structure and Domains
PDB ID
InterPro IPR012336 Thioredoxin-like fold
IPR013766 Thioredoxin domain
IPR017905 ERV/ALR sulfhydryl oxidase domain
PFAM PF13098
PF13192
PF13462
PF13905
PF00085
PF04777
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1MM32
UniProt Splice Variant
Entrez Gene 522986
UniGene Bt.64539
RefSeq NP_001095544
HUGO HGNC:9756
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02043485 DAAA02043486
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca